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Precis: Working patients with early-stage breast cancer who received more aggressive 
treatments were more likely to experience substantial employment disruptions.  Information 
regarding the impact of treatment decisions on employment is relevant for patient decision-
making. 
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ABSTRACT 
 
Background: Many patients with breast cancer work for pay at time of diagnosis, and the 
treatment plan may threaten their livelihood. Understanding work experiences in a contemporary 
population-based sample is necessary to inform initiatives to reduce the burden of cancer care.  
 
Methods: We surveyed women aged 20-79 years diagnosed with stages 0-II breast cancer as 
reported to the Georgia and Los Angeles SEER registries in 2014-15.  Of 3672 eligible women, 
2502 responded (68%); we analyzed 1006 who reported working before diagnosis.  
Multivariable models evaluated correlates of missing >1 month and stopping work altogether vs 
missing ≤1 month. 
  
Results: In this diverse sample, most patients (62%) received lumpectomy; 16% had unilateral 
mastectomy (8% with reconstruction); 23% had bilateral mastectomy (19% with reconstruction).  
One third (33%) received chemotherapy. Most (84%) worked full-time before diagnosis, but 
only 50% had paid sick leave, 39% disability benefits, and 38% flexible work schedules.  
Surgical treatment was strongly correlated with missing >1 month of work (OR 7.8 for bilateral 
mastectomy with reconstruction vs lumpectomy) and with stopping altogether (OR 3.1 for 
bilateral mastectomy with reconstruction vs lumpectomy).  Chemotherapy receipt (OR 1.3 for 
missing >1 month; OR 3.9 for stopping altogether) and race (OR 2.0 for missing >1 month; OR 
1.7 for stopping altogether; blacks vs whites) also correlated.  Those with paid sick leave were 
less likely to stop working (OR 0.5), as were those with flexible schedules (OR 0.3).  
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Conclusions: Working patients who received more aggressive treatments were more likely to 
experience substantial employment disruptions.   
 
Keywords: breast cancer, mastectomy, chemotherapy, employment, job, work 
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Introduction 
Work is an important source of income, insurance, and social interactions and may be 
particularly important for individuals with cancer, who may also find that it gives meaning to 
life, provides a welcome distraction, and improves quality of life.1,2  Unfortunately, cancer 
diagnosis and treatment can disrupt patient employment, particularly during active therapy but 
also in its aftermath.  Treatment plans are burdensome and exact a heavy toll on all aspects of 
quality of life--including physical functioning and emotional well-being--with protracted 
recovery times in some cases.  Financial toxicity, which can develop in part because of lost 
income, is an important, yet understudied potential threat to patient and family quality of life 
after diagnosis. 
 
Prior research regarding the impact of breast cancer diagnosis and treatment on employment 
experiences has yielded variable results, with some studies suggesting limited impact but others 
suggesting substantial and lasting effects.3-7  The divergence of prior study results may be 
explained in part by differences in study settings and population characteristics, the wide 
variation in relevant policies and culture in different nations, and changes in treatments offered 
over time.   
 
Our own prior work has shown that many patients with breast cancer are working for pay at time 
of diagnosis, that most women with breast cancer who are working for pay before diagnosis lose 
work time during treatment, and that many stop working altogether.5,6  Furthermore, loss of paid 
work during treatment can result in permanent and undesirable long-term unemployment.7  Thus, 
it is critical that treatments be no more burdensome than necessary and delivered in ways that 
minimize disruption for patients.  
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The growing awareness of the burden of cancer treatment is sparking initiatives to reduce it. Use 
of chemotherapy in early stage breast cancer is increasingly more selective,8 and increased 
attention to symptom control and management may be reducing avoidable morbidity in those 
who do receive treatment.9  By contrast, trends in surgical management may be increasing 
patient morbidity--for example, the increasing use of bilateral mastectomy, usually with breast 
reconstruction, in patients with unilateral cancer.10 But at the same time there are trends toward 
less extensive surgery--for example, decreased re-excision11 and use of axillary dissection after 
lumpectomy. Thus, there is a growing dichotomy in surgical management with major potential 
impact on patient recovery from treatment.  It is essential that we understand how this rapidly 
evolving treatment context may impact employment of women diagnosed with breast cancer.  
 
Policies regarding employment support for patients with cancer have also evolved in light of 
growing recognition of the importance of these issues,12,13 further motivating the need to 
examine the impact of treatment on employment of patients diagnosed in the United States 
today.  In this transformed landscape of public policy, medical evidence, and treatment options, 
we sought to document patterns and correlates of missed work in a contemporary population-
based sample of women recently diagnosed with breast cancer, with particular focus on 
associations of employment experiences with primary surgical treatment selected, to inform 
initiatives to support patients with cancer in their treatment decisions and transitions to 
survivorship.  
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Methods 
Study Sample and Data Collection  
After Institutional Review Board approval, including waiver of signed informed consent, we 
selected women aged 20-79 years and diagnosed with stages 0-II breast cancer who were 
reported to the Surveillance Epidemiology and End Results (SEER) registries of Georgia and 
Los Angeles County.  Eligible patients were identified via pathology reports from “definitive” 
surgical procedures (those intended to remove the tumor with clear margins) in 2014-15. Black, 
Asian, and Hispanic women were oversampled in Los Angeles using a previously described 
approach.14   Questionnaire content was developed using a conceptual framework, research 
questions, and hypotheses.  We developed measures drawing from the literature and our prior 
research.  We assessed content validity, including systematic review by design experts, cognitive 
pre-testing with patients, and pilot studies in clinic populations.15 
 
Data Collection  
Patient surveys were mailed with a $20 cash incentive, using a modified Dillman method,16 
including reminders to non-respondents (see Supplementary Material).  All materials were in 
English.  We added Spanish-translated materials for all women with surnames suggesting 
Hispanic ethnicity.  Survey responses were merged with SEER data.  Median time from 
diagnosis to survey completion was 7 months. 
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Measures 
As part of a larger questionnaire that evaluated patients’ treatment decisions and experiences 
after diagnosis of breast cancer, we asked patients if they worked for pay before their breast 
cancer diagnosis and asked their employment status (employed full-time, employed part-time, 
unemployed and looking for work, temporarily laid off or on sick or other leave, disabled, 
retired, student, homemaker).  We limited our analytic sample for the current study to those who 
reported working either full-time or part-time prior to diagnosis.   
 
Our primary dependent variable of interest was patient-reported missed work (days missed 
because of breast cancer or its treatment, with response options of none, less than a week, 7-14 
days, 15-30 days, more than a month, and stopped working altogether), which we then 
categorized for analysis as in our prior work using this measure as having missed 0-30 days, 
missed >30 days, or stopped working altogether.5 
 
Independent variables included patients’ clinical, treatment, sociodemographic, and 
employment-related characteristics.  All of these were measured by self-report except for tumor 
stage, which was taken from SEER registry data.  Specifically, the clinical factors we considered 
were age (measured continuously and categorized as 50 or less, >50 to 65, or >65 to 79), stage 
(AJCC Stage 0, I, or II), patient-reported comorbidities (presence of one or more medical 
comorbidities derived from a list pertinent to cancer patients) and overall health status 
(categorized as excellent, good, fair, or poor using the SF-1).  Treatment factors included 
chemotherapy receipt, radiotherapy receipt, axillary surgery (dichotomized as axillary lymph 
node dissection versus sentinel node biopsy alone or no surgical nodal intervention) and type of 
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breast surgery received (categorized as lumpectomy, unilateral mastectomy without 
reconstruction, unilateral mastectomy with reconstruction, bilateral mastectomy without 
reconstruction, or bilateral mastectomy with reconstruction).  Sociodemographic features 
included race/ethnicity (grouped as non-Hispanic White, non-Hispanic Black, non-Hispanic 
Asian, Latina, or other), educational attainment (high school or less, some college or technical 
school, or college graduate), household income (grouped as <$40,000, $40,000-$89,999, or 
>=$90,000), number of people supported by patient’s income, and marital status (married or 
partnered versus not).  Employment-related characteristics included self-reported full-time versus 
part-time status, work hours (grouped as 1-35, 36-44, or 45+), paid sick leave, disability benefits, 
flexible work schedule, and geographic site (Los Angeles vs. Georgia). 
 
In addition, we inquired, “Since your breast cancer diagnosis, how much money (income) have 
you lost due to time off from work?”  Response options were 0, $1-$500, $501-$2000, $2001-
$5000, $5001-$10,000, or more than $10,000. 
 
Statistical Analyses 
After limiting the study sample to those who had been working before diagnosis, we described 
the study sample and its characteristics by amount of missed work (0-30 days, >30 days, or 
stopped altogether).  Next, we constructed a multivariable multinomial logistic regression model 
of the missed work outcome, using 0-30 days as the reference category.  Independent variables 
included all of the clinical, treatment, sociodemographic and employment-related characteristics 
listed above, except work hours (to avoid collinearity with self-reported full-time versus part-
time status).  Multivariable analysis used listwise deletion for all missing data; less than 3% of 
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cases were excluded due to missing data.  Finally, we described the amount of lost income by 
amount of missed work and compared using the chi-squared test. Using the midpoints of the 
ranges for the survey questions on household income and income lost due to time off from work, 
we also estimated the percent of annual income lost. Analyses were conducted using SAS 9.4 
and p-values of <0.05 were considered significant. 
 
Survey design and non-response weights were used in all analyses to compensate for the 
differential probability of selecting patients and survey non-response.17  All percentages and 
odds ratios reported herein are weighted and numbers of participants, when provided, are 
unweighted for clarity.  Given low levels of item non-response, complete case methods were 
used; analyses of data using multiply imputed data (not shown) were consistent with results that 
we report here. 
  
Results 
As shown in Figure 1, of the 3930 women diagnosed in 2014-15 we initially selected for our 
sample based on rapid case ascertainment (which allows earlier survey administration by 
reducing the time lag from diagnosis to case identification),18 258 were subsequently found to be 
ineligible due to prior breast cancer diagnosis or stage III-IV disease; residing outside the SEER 
registry area; or being deceased, too ill or unable to complete a survey in Spanish or English.  Of 
3672 eligible women remaining, 1170 could not be contacted or did not participate, leaving 2502 
respondents (68%).  Of these, we considered the 1006 women who reported that they had been 
working before diagnosis for further analysis in this study.   
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Table 1 shows the characteristics of the analytic sample, which was racially and ethnically 
diverse (48% white, 19% black, 20% Latina, and 11% Asian).  Most patients (62%) received 
lumpectomy; 16% had unilateral mastectomy (8% with reconstruction); 23% had bilateral 
mastectomy (19% with reconstruction).  One third (33%) received chemotherapy.  The vast 
majority (84%) reported working full time before diagnosis, but only half (50%) had jobs that 
allowed for paid sick leave, 39% had disability benefits, and 38% had a flexible work schedule.   
 
Bivariable associations between employment experiences and patient characteristics are provided 
in Supplementary Table 1.  On multivariable analysis, including treatment and clinical factors 
alone, several factors were significantly correlated with missing more than a month of work or 
stopping work altogether as compared to missing up to 30 days (Table 2).  Those with poorer 
health (vs. excellent health) were overall less likely (p<0.001) to miss work (OR for stopping 
work altogether 2.5, 95% CI 1.2-5.1).  Chemotherapy receipt also correlated with stopping work 
(OR 1.3, 95% CI 0.8-2 for missing over one month and OR 3.9, 95% CI 2.6-5.8 for stopping 
work altogether).  Surgical treatment was strongly correlated with missing over one month of 
work (OR 7.8, 95% CI 4.5-13.4, for bilateral mastectomy with reconstruction, compared to 
lumpectomy) and with stopping work altogether (OR 3.1, 95% CI 1.6-5.9, for bilateral 
mastectomy with reconstruction, compared to lumpectomy).  Race was correlated with missed 
work (p=0.01).  For blacks versus whites, the OR for missing over one month was 2.0 (95% CI 
1.3-3.2) and for stopping work altogether was 1.7 (95% CI 1.1-2.8).  Those with paid sick leave 
were less likely to stop working altogether (OR 0.5, 95% CI 0.3-0.7).  Those with flexible work 
schedule were less likely to stop working altogether (OR 0.3, 95% CI 0.2-0.5) or to miss more 
than a month of work (OR 0.7, 95% CI 0.5-1).  Conversely, women with disability benefits were 
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more likely to stop working (OR 1.6, 95% CI 1-2.4) or miss over a month of work (OR 2.7, 95% 
CI 1.8-3.9).  Also significant were study site (with patients from Georgia less likely to miss over 
a month of work, OR 0.6, 95% CI 0.4-0.8), household income (with the highest income group 
with income ≥$90,000 having an OR of 0.6, 95% CI 0.3-1, for stopping work), and number 
supported by family income (with those whose household income supported ≥4 persons being 
less likely to stop working altogether, OR 0.4, 95% CI 0.2-0.8). Of note, 7% of patients (13% of 
those receiving radiotherapy) were still receiving radiotherapy at the time of survey; excluding 
these patients did not affect the significance of any covariates in the model. 
 
Figure 2 shows adjusted rates of missed work, by surgical treatment received.  Patients receiving 
lumpectomy were far less likely to miss over a month of work or stop working altogether, as 
compared to women receiving mastectomy.  
 
Those who missed more work also reported losing greater amounts of income due to time off 
from work since breast cancer diagnosis (p<0.001), as shown in Table 3.  Specifically, among 
those who missed 0-30 days, 74% lost $0-$500 and only 6% lost >$5000.  Among those who 
missed more than 30 days, 40% lost 0-$500 and 29% lost >$5000.  Among those who stopped 
working altogether, 17% lost 0-$500 and 54% lost >$5000.  The median patient reported losing 
3.6% of their annual household income due to time off from work, and 19% of patients reported 
losing 10% or more of their annual household income  
 
Of the women in our analytic sample, all of whom had been employed before diagnosis, 65% 
reported that their current employment status at time of survey was full-time employment, 15% 
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reported part-time employment (including 38 of the 844 women who had been working full-time 
before diagnosis), 3% were unemployed and looking for work, 6% were temporarily laid off or 
on sick or other leave, 4% were disabled, 4% were retired, 1% were students, and 2% were 
homemakers.    
 
Discussion 
In this large, modern and diverse cohort of patients newly diagnosed with breast cancer, we 
observed striking variations in rates of missed work by type of surgery received, along with 
findings consistent with prior research regarding the impact of chemotherapy, sociodemographic 
factors, and the employment context.  These findings are important because never before have 
women with breast cancer faced such a wide range of choices for surgical management, nor has 
the dichotomy in surgical treatment options been more dramatic.  Some women receive breast 
conservation, while others receive bilateral mastectomy for exactly the same condition, often 
also with reconstruction.  Understanding the employment effects of different surgical decisions is 
critically important to the many patients who consider more aggressive surgical treatments than 
medically necessary to treat their cancer.  Surgeons who treat patients with breast cancer can 
now provide compelling evidence that women who receive mastectomy experience considerably 
higher risks of missed work than those who receive breast conserving therapy.  Moreover, the 
current data allow quantification of the financial impact of this missed work—data that may be 
very useful in helping patients understand the full impact of treatment decisions.   
 
Strikingly, the magnitude of risk to employment with more aggressive surgery observed in this 
study was similar to the risks associated with chemotherapy, which has traditionally been the 
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major target of efforts to reduce the burden of cancer care.  Indeed, most prior studies of 
immediate treatment impact on breast cancer patients’ employment19,20 have focused on 
chemotherapy. Several studies have suggested that patients who received chemotherapy were 
most likely to experience disruptions in employment21 and prolonged absences.22  Although 
evidence has been more mixed regarding the long-term effects of treatment on employment, with 
some studies suggesting that breast cancer treatment and particularly adjuvant chemotherapy 
might not delay or prevent ultimate return to work,3,4 there is reason to believe that the adverse 
effects of chemotherapy on employment may be long lasting.  In our group’s prior work, 
adjuvant chemotherapy receipt was associated with long-term job loss among survivors at four 
years, and many of these women were actively seeking employment, suggesting that this was 
involuntary.7  Women who lacked employment support (sick leave or flexible hours) were most 
vulnerable.  Studies in other settings, including ones with greater employment support, have also 
documented greater rates of job discontinuation or decreased work time among breast cancer 
survivors who received chemotherapy.23  Moreover, recent research has highlighted how certain 
women, including those with low income, may be particularly vulnerable to the risk of not 
returning to work in the months and years after treatment.24 
 
As Hassett and colleagues noted in relevant prior work, these findings “reinforce the need to 
assess the impact of treatments, especially new treatments, on patient-centered outcomes such as 
employment.”  Of note, at the time of most prior studies, rates of mastectomy overall were 
considerably lower than in the current era, and bilateral mastectomy was rarely used, so it was 
not evaluated separately from unilateral mastectomy in terms of impact on employment.  
However, in recent years, in the wake of celebrity disclosures and growing patient interest, rates 
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of mastectomy overall and particularly in combination with contralateral prophylactic 
mastectomy have surged:  more than one in five patients in the current sample of working 
patients had bilateral mastectomy.  Although some women with early-stage breast cancer are not 
candidates for breast conservation, most are.  Therefore, it is crucial to ensure that patients are 
fully informed of the risks of treatment, including the potential for impact on employment (a 
critical component of financial toxicity) to optimize the true goals of shared decision-making.  
With the growing use of mastectomy, further research is necessary to monitor whether the short-
term impact of more aggressive surgery that was observed in the current study will also translate 
into longer term consequences for these women’s employment and well-being. 
 
Prior research has emphasized the importance of workplace accommodations in promoting return 
to work.25,26  In our current study, flexible work arrangements were associated with substantial 
decreases in missing over 30 days of work or stopping altogether, although disability benefits 
were found to have the converse association, suggesting that some missed work may reflect the 
ability of a patient to take the time she needs to recover.  Nevertheless, even after accounting for 
flexibility and other workplace policies, treatments, and particularly more aggressive surgery, 
had a strong effect that merits note. 
 
Although our study has numerous strengths, including its large and recent sample drawn from 
population-based registries, it also has limitations that merit consideration.  First, as in any 
observational study, correlation may not imply causation.  Still, there is little reason to believe 
that those who selected more aggressive treatments were predisposed to missing or stopping 
work, after adjusting for multiple sociodemographic and employment factors.  Second, not all 
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missed work is necessarily concerning; voluntary time off might benefit patients by giving them 
a chance to cope with diagnosis and treatment.  Further research is necessary to determine 
whether the short-term impact we observed translates into long-term challenges, particularly 
among the youngest patients, with the greatest years of potential employability, who most often 
selected the most aggressive surgical options.  Third, this study was intended to assess 
associations between treatment and employment outcomes; therefore, it included only patients 
diagnosed with breast cancer and not non-cancer patients from the population.  Although studies 
evaluating the employment effects of cancer diagnosis in patients as compared to healthy 
controls are important, the inclusion of healthy controls was not necessary to study the treatment 
effects that we sought to evaluate here.  Fourth, because patients were surveyed relatively after 
diagnosis to minimize recall bias, a minority were still completing adjuvant therapy, and the full 
impact of such treatments (and particularly radiotherapy) might not be appreciated given the 
timing of survey administration.  Fifth, to minimize respondent burden in the context of a larger 
study evaluating breast cancer treatment decisions, only select employment-related factors were 
evaluated.  We hope to conduct follow-up research with this cohort as they proceed further into 
the survivorship phase, which will allow us to capture long-term, detailed measures of 
employment-related constructs of importance to patients.  Finally, our study was conducted in 
two large U.S. areas; the results should be generalized with caution to other U.S. settings and not 
at all to countries with markedly dissimilar employment support policies or culture. 
 
 
Implications for clinical care 
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Our results show that treatment has a profound effect on return to work in the modern era, 
despite improvements in symptom control and changes in social policy.  In addition to policies 
that further improve employment support, practical actions by clinicians to reduce the overuse of 
aggressive treatments are of critical importance.  In particular, when counseling patients 
regarding surgical treatment options, the potential impact on employment outcomes and financial 
impact quantified in this study merits discussion to ensure that patients make choices fully 
informed regarding potential consequences. 
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Figure Legends:  
Figure 1: Flow diagram of study participants 
 
Figure 2: Amount of work lost by breast cancer surgical treatment 
This figure depicts marginal probabilities of missed work by surgical treatment, derived from a 
multivariable model adjusting for age, stage, co-morbidities, health status, chemotherapy, 
radiotherapy, ALND, race, education, marital status, geographic site, employment status, job 
benefits, income, and household size, weighted to reflect sampling and response rates. 
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Tables: 
Table 1: Distribution of patients by selected clinical, treatment, sociodemographic, and 
employment-related characteristics 
  N* 
% 
(column)** 
Age at Diagnosis     
50 or less 353 35% 
51-65 550 55% 
66-79 103 10% 
Stage 
    
0 196 20% 
I 526 53% 
II 263 27% 
Any Co-Morbidities     
No 789 78% 
Yes 217 22% 
Health Status     
Poor 8 1% 
Fair 97 10% 
Good 371 37% 
Very Good 404 41% 
Excellent 117 12% 
Chemotherapy     
No chemotherapy 658 67% 
Chemotherapy 327 33% 
Radiotherapy     
No radiotherapy 474 48% 
Radiotherapy 518 52% 
Surgical Treatment     
Lumpectomy 608 62% 
Unilateral mastectomy without    
reconstruction 77 8% 
Unilateral mastectomy with 
reconstruction 81 8% 
Bilateral mastectomy without 
reconstruction 38 4% 
Bilateral mastectomy with 
reconstruction 184 19% 
Axillary Lymph Node Dissection     
No ALND 917 91% 
ALND 89 9% 
Race     
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  N* 
% 
(column)** 
Non-Hispanic White 485 48% 
Non-Hispanic Black 188 19% 
Latina 201 20% 
Non-Hispanic Asian 115 11% 
Other 17 2% 
Education     
High school or less 231 23% 
Some college or technical school 298 30% 
College graduate or more 460 47% 
Marital Status     
Not partnered 367 37% 
Married/partnered 625 63% 
Site     
Georgia 510 51% 
Los Angeles 496 49% 
Employment Status     
Part Time 162 16% 
Full Time 844 84% 
Work Hours/Week     
1-35 hrs/week 213 22% 
36-44 hrs/week 562 57% 
45+ hrs/week 207 21% 
Paid Sick Leave 
    
No 504 50% 
Yes 502 50% 
Disability Benefits 
    
No 613 61% 
Yes 393 39% 
Flexible Work Schedule 
    
No 624 62% 
Yes 382 38% 
Household Income 
    
<$40,000 255 28% 
$40,000 - $89,999 330 36% 
$90,000 + 337 37% 
People Supported by Household Income 
    
1 (Self only) 239 24% 
2 369 37% 
3 173 18% 
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  N* 
% 
(column)** 
4 Or More 204 21% 
*Unweighted number. 
**Weighted percentage (to compensate for differential probability of selection and survey non-
response). 
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Table 2: Adjusted odds ratios for work loss by sociodemographic, clinical, and employment-
related factors 
  
Missed >1 month vs. 
missed ≤1 month OR 
[95% CI] 
Stopped working  vs. 
missed ≤1 month OR 
[95% CI] P value 
Age     0.158 
50 or less (ref) 1.0 1.0   
51-65 0.7 (0.4, 1) 0.7 (0.4, 1)   
66-79 0.3 (0.1, 0.5) 0.7 (0.4, 1.2)   
Stage 
    
0.174 
0 (ref) 1.0 1.0   
I 1.4 (0.9, 2.2) 1.3 (0.8, 2)   
II 1.4 (0.8, 2.5) 1.4 (0.8, 2.4)   
Any Co-Morbidities 0.8 (0.6, 1.3) 0.7 (0.5, 1) 0.285 
Health Status 
    
<.001 
Poor, Fair 1.3 (0.6, 2.7) 2.5 (1.2, 5.1)   
Good 1.7 (0.9, 3.1) 1.7 (0.9, 3.3)   
Very Good 1.1 (0.6, 1.9) 0.8 (0.4, 1.6)   
Excellent (ref) 1.0 1.0   
Chemotherapy 1.3 (0.8, 2) 3.9 (2.6, 5.8) <.001 
Radiotherapy 1.1 (0.7, 1.7) 1.2 (0.7, 1.8) 0.488 
Surgical Treatment 
    
<.001 
Lumpectomy (ref) 1.0 1.0   
Unilateral mastectomy without 
reconstruction 4.0 (2.1, 7.7) 2.5 (1.3, 4.9)   
Unilateral mastectomy with 
reconstruction 4.0 (2.1, 7.5) 2.3 (1.2, 4.5)   
Bilateral mastectomy without 
reconstruction 2.6 (1, 7.1) 2.9 (1.3, 6.6)   
Bilateral mastectomy with 
reconstruction 7.8 (4.5, 13.4) 3.1 (1.6, 5.9)   
Axillary Lymph Node Dissection 
    0.300 
No ALND 1.0 1.0   
ALND 0.5 (0.3, 1.1) 0.8 (0.5, 1.5)   
Race 
    
0.014 
Non-Hispanic White (ref) 1.0 1.0   
Non-Hispanic Asian 1.6 (0.9, 2.8) 2.6 (1.4, 4.8)   
Non-Hispanic Black 2 (1.3, 3.2) 1.7 (1.1, 2.8)   
Latina 1.4 (0.9, 2.4) 2.1 (1.2, 3.7)   
Other 0.5 (0.1, 4.5) 2.8 (0.9, 8.8)   
Education 
    
0.846 
High school or less (ref) 1.0 1.0   
Some college or technical school 1 (0.6, 1.6) 1.4 (0.9, 2.2)   
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Missed >1 month vs. 
missed ≤1 month OR 
[95% CI] 
Stopped working  vs. 
missed ≤1 month OR 
[95% CI] P value 
College graduate 0.9 (0.5, 1.5) 1 (0.6, 1.6)   
Married/partnered 0.9 (0.6, 1.5) 1.5 (0.9, 2.3) 0.546 
Georgia (vs. Los Angeles) 0.6 (0.4, 0.8) 0.8 (0.5, 1.2) 0.004 
Part Time 0.3 (0.2, 0.5) 1 (0.6, 1.5) 0.252 
Paid Sick Leave 1.3 (0.9, 2) 0.5 (0.3, 0.7) 0.002 
Disability Benefits 2.7 (1.8, 3.9) 1.6 (1, 2.4) <.001 
Flexible Work Schedule 0.7 (0.5, 1) 0.3 (0.2, 0.5) <.001 
Household Income 
    
0.043 
<$40,000 (ref) 1.0 1.0   
$40,000 - $89,999 0.8 (0.5, 1.3) 0.6 (0.4, 0.9)   
    $90,000 +  0.6 (0.4, 1.1) 0.6 (0.3, 1)   
People Supported by Household Income 
    
0.009 
Self only (ref) 1.0 1.0   
2 1.2 (0.7, 2) 0.7 (0.4, 1.1)   
3 1.3 (0.7, 2.4) 1.3 (0.7, 2.3)   
4 or more 1.3 (0.7, 2.5) 0.4 (0.2, 0.8)   
Odds ratios produced from a multiple variable logistic regression model. Model incorporates 
weights to adjust for sampling and response rates. P-value represents Chi-square overall test for 
association. 
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Table 3: Amount of missed work by income reported lost due to work loss, by amount of work 
missed 
 
 Zero to 30 days missed More than 30 days missed Stopped working 
Income Lost Due to 
Time Off From Work n 
Column % 
(weighted) n 
Column % 
(weighted) n 
Column % 
(weighted) 
$0  298 66% 121 37% 22 14% 
$1 to $500 37 8% 10 3% 5 3% 
$501 to $2,000 54 12% 57 16% 15 8% 
$2,001 to $5,000 34 8% 55 16% 35 22% 
$5,001 to $10,000 14 3% 63 18% 33 20% 
More than $10,000 12 3% 35 11% 60 34% 
*percentages are weighted to reflect sampling and response rates 
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Supplemental Material 
 
Supplementary Table 1: Amount of missed work by selected patient characteristics (bivariable 
analyses) 
 
  
 Zero 
to 30 
days 
missed 
More 
than 
30 
days 
missed 
Stopped 
working 
P 
value 
Age at Diagnosis       <.001 
50 or less 40% 44% 16% 
  
51-65 53% 31% 16% 
  
66-79 57% 21% 22% 
  
Stage 
      <.001 
0 58% 34% 8% 
  
I 51% 35% 14% 
  
II 35% 32% 33% 
  
Any Co-Morbidities       0.352 
No 49% 35% 16% 
  
Yes 50% 30% 20% 
  
Health Status       <.001 
Poor 0% 20% 80% 
  
Fair 32% 32% 37% 
  
Good 41% 37% 22% 
  
Very Good 58% 33% 9% 
  
Excellent 60% 30% 9% 
  
Chemotherapy       <.001 
No chemotherapy 57% 34% 9% 
  
Chemotherapy 31% 34% 35% 
  
Radiotherapy       <.001 
No radiotherapy 37% 44% 20% 
  
Radiotherapy 60% 26% 14% 
  
Surgical Treatment       <.001 
Lumpectomy (ref) 63% 23% 14% 
  
Unilateral mastectomy without reconstruction 19% 41% 40% 
 
Unilateral mastectomy with reconstruction 26% 49% 25% 
 
Bilateral mastectomy without reconstruction 31% 36% 32% 
 
Bilateral mastectomy with reconstruction 27% 61% 12% 
 
Axillary Lymph Node Dissection       <.001 
No ALND 49% 35% 15% 
  
ALND 45% 22% 33% 
  
Race       <.001 
    Non-Hispanic White 58% 30% 12% 
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 Zero 
to 30 
days 
missed 
More 
than 
30 
days 
missed 
Stopped 
working 
P 
value 
    Non-Hispanic Black 35% 45% 20% 
  
    Latina 37% 36% 27% 
  
Non-Hispanic Asian 45% 36% 19% 
  
Other 57% 18% 25% 
  
Education       <.001 
High school or less 39% 34% 27% 
  
Some college or technical school 50% 33% 18% 
  
    College graduate or more 53% 35% 12% 
  
Marital Status       0.042 
Not partnered 47% 32% 21% 
  
Married/partnered 50% 35% 15% 
  
Site       0.115 
Georgia 52% 33% 15% 
  
Los Angeles 46% 35% 19% 
  
Employment Status       0.039 
Part Time 53% 26% 21% 
  
Full Time 48% 36% 16% 
  
Work Hours/Week       0.011 
1-35 hrs/week 52% 25% 22% 
  
36-44 hrs/week 48% 37% 14% 
  
    45+ hrs/week 48% 37% 15% 
  
Paid Sick Leave 
      <.001 
No 47% 28% 25% 
  
Yes 51% 40% 9% 
  
Disability Benefits 
   <.001 
No 58% 26% 17% 
  
Yes 35% 47% 17% 
  
Flexible Work Schedule 
      <.001 
    No 39% 38% 23% 
  
Yes 65% 28% 7% 
  
Household Income 
      <.001 
    <$40,000 35% 33% 32% 
  
$40,000 - $89,999 53% 35% 12% 
  
$90,000 + 55% 34% 11% 
  
People Supported by Household Income 
      <.001 
1 (Self only) 50% 28% 21% 
  
2 54% 32% 14% 
  
3 40% 35% 25% 
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 Zero 
to 30 
days 
missed 
More 
than 
30 
days 
missed 
Stopped 
working 
P 
value 
    4 Or More 45% 45% 9% 
*percentages are weighted to reflect sampling and response rates 
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Figure 1: Flow diagram of study participants  
 
171x128mm (300 x 300 DPI)  
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Figure 2: Amount of work lost by breast cancer surgical treatment  
This figure depicts marginal probabilities of missed work by surgical treatment, derived from a multivariable 
model adjusting for age, stage, co-morbidities, health status, chemotherapy, radiotherapy, ALND, race, 
education, marital status, geographic site, employment status, job benefits, income, and household size, 
weighted to reflect sampling and response rates.  
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Individualized Cancer Care 
A study examining women’s breast cancer 
treatment experiences and decision making 
 
Conducted by:   Keck School of Medicine at the University of Southern California, 
Emory University, and the University of Michigan 
 
 
 
 
 
 
 
 
 
 
 
This study is funded by a grant from the National Cancer Institute and has been approved by the Institutional 
Review Boards of Emory University, the University of Southern California, and the University of Michigan. 
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le  Answer each question as best you can. Please do not leave any blank. However, if you fe l that you do not wish to answer a question, please write ‘skip’ next to it and continue on to the next question. 
 
 
 Put an  or fill in the circle        next to your answer.  
Example:   Yes       or     Yes 
 
 
 Please erase or cross your answer out completely if you want to change your answer. 
Example:   Yes        
 
 
 Mark only one response for each question unless other instructions are given, 
such as “Mark ALL that apply”. 
 
 
 Please follow any instructions or arrows that direct you to the next question. 
Exam le:     No                    Please go to F9 on the next page. 
 
 
 If you mark an answer with a line after it, please write the specific information          
on the line.  
Example:     Other (please explain):    
 
 
 
General Instructions 
       
PLEASE READ THESE INSTRUCTIONS CAREFULLY
 
 
 
 
 
 
 
Please be reminded that your responses to this survey are confidential and will not be shared 
with your doctors. 
D 
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Section A:  How Are You Doing? 
 
In general… Excellent Very good Good Fair Poor 
A1. Would you say your health is …      
A2. Would you say your quality of life is …      
A3. How would you rate your physical health?      
A4. How would you rate your mental health, 
including your mood and your ability to think? 
     
A5. How would you rate your satisfaction with 
your social activities and relationships? 
     
 
 Excellent Very good Good Fair Poor 
A6. In general, please rate how well you carry out 
your usual social activities and roles.  
(This includes activities at home, at work, and 
in your community, and responsibilities as a 
parent, child, spouse, employee, friend, etc.) 
     
 
Completely Mostly Moderately A little 
Not  
at all 
A7. To what extent are you able to carry out 
your everyday physical activities, such as 
walking, climbing stairs, carrying 
groceries, or moving a chair? 
     
 
  
    
    Never Rarely Sometimes Often Always 
A8. In the past 7 days, how often have you 
been bothered by emotional problems 
such as feeling anxious, depressed, or 
irritable? 
     
 
 None Mild Moderate Severe 
Very 
severe 
A9. How would you rate your fatigue on average? 
     
 
 
 
 
No 
pain 
 
 
        
 
Worst 
imaginable 
pain 
A10. How would you rate 
your pain on average? 
           
 
 
 
 
D 
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A11. How are you doing overall?  
 
 
 
 
 
 
 
 
 
 
A12. Please tell us whether you have ever been told by a doctor that you had any of the following              
health conditions:   
  Yes    No  
  
a. Chronic bronchitis or emphysema 
  b. Heart disease, such as coronary artery disease or congestive heart failure 
  c. Diabetes 
  d. Blood clots in the legs or the lung 
  e. Connective tissue disease, such as lupus or scleroderma 
 
 
f. Stroke 
  g. Depression 
  
h. High cholesterol 
 
 i. High blood pressure or hypertension 
 
 
 
 
Please look at the thermometer to the right and write in the 
number from 0-10 on the line below that best describes 
how much distress you have been experiencing in the 
past 7 days, including today: 
 
_________ (0-10) 
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Section B:  Diagnosis and Testing of Your Cancer 
B1.  How was a problem with your breast first discovered? Please mark ONE. 
The breast cancer was first detected on a routine mammogram 
A doctor or nurse found a lump during a breast exam 
I or my husband/partner found a lump  
I noticed other breast symptoms such as pain, skin change, redness or nipple discharge 
Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
B2.  What was the date when you were first diagnosed with breast cancer? 
 
B3. How did you first find out that you had breast cancer?  Please mark ONE. 
Radiology doctor who did my biopsy told me 
My primary care doctor told me 
My surgeon called and told me before my first visit with him/her 
My surgeon told me during my first visit with him/her 
A nurse told me before my first visit with a  surgeon 
Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
Next, please tell us about the tests you received to evaluate your breast cancer. 
 
Biopsy 
B4. A biopsy is a procedure where tissue or cells are taken from the breast to test for cancer.  On which 
breast did you have a biopsy to diagnose your cancer? 
   
Left Right Both 
 
 
B5. When you first had your biopsy or biopsies that found the cancer, were you told you had cancer in 
both breasts?  
   
Yes No Don’t know 
 
B6. One type of biopsy is a needle biopsy. It uses a hollow needle inserted in the breast with local numbing 
medicine to remove a small amount of tissue from your breast.  Sometimes a special imaging machine is 
used to locate the right tissue to remove.     
  
 
 
 
 
________ /  ________ 
   month          year 
 
Before a breast operation, was a needle biopsy 
used to diagnose your breast cancer?   
 
 
  Yes              No            
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Breast MRI 
Next, we would like to ask you about a Breast MRI (magnetic resonance imaging test). A Breast MRI is a scan 
in which a patient lies down and is placed inside a machine that uses a powerful magnet to take pictures of the 
breast.  The machine is very noisy.  Patients are asked before the test about any metal in the body.    
 
B7. How involved were you in deciding whether or not to have a Breast MRI to evaluate the extent of your 
breast cancer? 
     
 
Not at all 
involved 
A little  
involved 
Somewhat 
involved 
Quite  
involved 
Very  
involved 
 
 
B8. After diagnosis, did you have a Breast MRI to evaluate the extent of your breast cancer? 
 
     Yes 
 
     No 
     Don’t know 
 
Other Imaging Tests 
B9. How involved were you in deciding whether or not you had other imaging tests – such as CT scans or bone 
scans – to find out if cancer had spread to other places in your body? 
     
 
Not at all 
involved 
A little  
involved 
Somewhat 
involved 
Quite  
involved 
Very  
involved 
 
 
Genetic Testing for Cancer Risk 
Genetic testing for cancer risk – often called BRCA tests or multi-gene panel tests – looks for gene mutations or 
changes to see if women and their families have a greater risk of developing breast cancer in the future. 
 
B10. Did a doctor or other health professional talk with you about having a genetic test for breast cancer risk? 
   
Yes No Don’t know 
 
B11. Did you have a counseling session with a genetic counseling expert – that is, an appointment where the 
whole discussion is about genetic risk for breast cancer? 
   
Yes No Don’t know 
 
B12. How much did you want to have a genetic test to tell you the risk of you or your family developing new 
cancers in the future? 
    
 
 
Not at all A little bit Somewhat Quite a bit Very much 
 
B8a. Did the results of the Breast MRI change your decision 
about what type of surgery to have for your breast cancer? 
                 Yes                      No                     Don’t know 
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B13. Has a family member ever had a genetic test to determine if they carry a gene mutation (or change) for 
breast cancer? 
   
Yes No Don’t know 
 
B14. Does any member of your family have a gene mutation that increases the risk of breast cancer? 
   
Yes No Don’t know 
 
B15. Genetic tests for breast cancer risk are ordered by a doctor or genetic counselor and can be done with 
either a blood test or a saliva test where you rinse your mouth with mouthwash and spit into a tube.   
Have you ever had a blood or saliva genetic test for breast cancer risk that was ordered by a doctor or 
genetic counselor? 
   
Yes No Don’t know 
 
 
 
 
 
 
 
 
 
 
 
 
B16. Why did you get a genetic test?  Please mark ALL that apply. 
 
     My doctor thought I should 
 
     Because of my family history 
 
     My family wanted me to be tested 
 
     To help me decide about my treatment 
     I wanted to get more information about my own health 
 
     Other (please explain): _ _ _ _ _ _ _ _  
 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
     I wanted to get more information for my family members 
 
 
B15a. Why haven’t you had a genetic test for breast cancer risk?                        
Please mark ALL that apply. 
I plan to have a genetic test in the future 
I don’t know if I’ve had a genetic test 
My doctor didn’t recommend it 
I didn’t want it 
My family didn’t want me to get it 
It was too expensive 
I was afraid I would lose my insurance or have to pay more for insurance 
I was afraid of discrimination 
Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Please go to B22 “Tumor Tests” on page 7 
Please continue to B17 at the top of the next page 
Page 39 of 76 Cancer
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
6 
 
 
 
 
B17. When did you have the genetic test? 
   
Before I was diagnosed     
with breast cancer 
After I was diagnosed   
but before I had surgery 
After I had surgery                
to treat my breast cancer 
 
B18. What was the result of the genetic test?  Please mark ONE. 
            I did not have any mutations in the gene tests 
 
            I had a mutation in the BRCA1 or BRCA2 gene that increases the risk of breast cancer 
 
         I had a mutation in another gene (not BRCA1 or BRCA2) that increases the risk of breast cancer 
 
            A gene change was found, but not one that has been shown to increase the risk of breast cancer  
           (sometimes called a “variant of uncertain significance”) 
 
            I don’t know the results 
 
            Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
 
B19. Which provider ordered your genetic test?  Please mark ONE. 
      
Surgeon Medical 
oncologist 
Primary care 
provider 
Genetic 
counselor 
Other (please explain:)   
 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Don’t know 
 
 
 
B20.  Which provider(s) discussed the genetic test results with you?  Please mark ALL that apply. 
 Surgeon  Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 Medical oncologist  Don’t know 
 Primary care provider  N/A – I don’t have results yet 
 Genetic counselor   
 
 
B21.  Did the genetic test results influence your decision about whether or not to have both breasts removed? 
      
I was never   
interested in having 
both breasts removed 
Made me 
much less 
interested  
Made me 
less  
interested  
Did not influence 
my decision 
Made me   
more  
interested 
Made me       
much more 
interested  
If you have NOT had a genetic test for breast cancer risk, please skip this page and go to B22 
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Tumor Tests 
Some patients have their cancer tumor sent for additional testing. 
Examples of this type of test are Oncotype DX® and 
Mammaprint/Symphony®.   
 
B22. How involved were you in deciding whether or not to have the Oncotype DX or Mammaprint/Symphony 
test to find out whether you would benefit from chemotherapy? 
     
 
Not at all 
involved 
A little  
involved 
Somewhat 
involved 
Quite  
involved 
Very  
involved 
 
B23.  Was your cancer tumor sent for the Oncotype DX or Mammaprint/Symphony test?  
    
Yes  No Don’t know 
 
 
B24.  What were the results of the Oncotype DX or Mammaprint test for your tumor? 
    
Low risk Intermediate risk  High risk I don’t remember 
 
B25.  How helpful was the Oncotype DX or Mammaprint test in making a decision about whether or not to 
get chemotherapy?  
     
Not at all  
helpful 
A little  
helpful 
Somewhat  
helpful 
Very  
helpful 
Extremely  
helpful 
B26.  Did the Oncotype DX or Mammaprint test change your mind about whether or not to get chemotherapy? 
     
Made me much 
less interested in 
chemotherapy 
Made me 
less interested in 
chemotherapy 
Did not change 
my mind 
Made me more 
interested in 
chemotherapy 
Made me much 
more interested 
in chemotherapy 
 
B27.  How helpful was the Oncotype DX or Mammaprint test in making a decision about whether or not to 
get radiation therapy?  
     
Not at all  
helpful 
A little  
helpful 
Somewhat  
helpful 
Very  
helpful 
Extremely  
helpful 
B28.  Did the Oncotype DX or Mammaprint test change your mind about whether or not to get radiation 
therapy? 
     
Made me much 
less interested in 
radiation therapy 
Made me 
less interested in 
radiation therapy 
Did not change 
my mind 
Made me more 
interested in 
radiation therapy 
Made me much 
more interested in 
radiation therapy 
 
Please go to C1 at the top 
of the next page 
Please continue to C1 on the next page 
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Section C:  Your Treatments 
C1. Before your surgery, did you consult with any of these providers about your treatment decisions? 
Yes No  
  a. Radiation oncologist (a doctor who specializes in radiation treatment) 
  b. Medical oncologist (a doctor who specializes in chemotherapy) 
  
c. Plastic surgeon (a doctor who performs breast reconstruction) 
  d. Primary care provider (a doctor, physician assistant, or nurse practitioner who    
sees you for common problems or standard checkups) 
  e. Genetic counselor (someone who reviews your family history and explains the 
purpose and results of genetic tests) 
  f. Navigator (often a nurse, someone who helps you with your treatment schedule,  
test results, or who gives you and your family information about breast cancer) 
 
 
Surgery 
C2.  What was the first surgery that you had to remove your breast cancer after the biopsy test? 
 
I did not have any surgery after the biopsy  
 
I had a mastectomy (removal of the entire breast)            
 
 
I had a lumpectomy (removal of the cancer and some surrounding tissue)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a. Did you have a second lumpectomy to remove more breast tissue from the same breast? 
       Yes – I had another lumpectomy to remove more breast tissue from the same breast 
       
No – I only had one lumpectomy 
 
b. Did you have a mastectomy later, on the same breast? 
Yes – I had a mastectomy after my lumpectomy 
 
No – I did not have a mastectomy 
             
c. How strongly did your doctor recommend that you have a mastectomy after your initial 
lumpectomy?  
     
 
Very strongly Strongly Moderately Weakly Not at all 
 
d. How strongly did you request to have a mastectomy after your initial lumpectomy?  
     
 
Very strongly Strongly Moderately Weakly Not at all 
     
 
 
Please go to C3 at the top of 
the next page 
Please continue to C3 on the next page 
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C3.  What kind of mastectomy did you have?   
 I did not have a mastectomy 
 
Mastectomy only – no reconstruction 
 Mastectomy with reconstruction and I kept my own nipple, called a nipple sparing 
or nipple saving mastectomy 
  
Mastectomy with reconstruction and my original nipple was removed 
 
C4.  What type of breast reconstruction did you have? 
 
  I have not had any breast reconstruction surgery 
 
A DIEP flap, TRAM flap, or latissimus dorsi flap (uses your own tissue from the abdomen or back) 
 
An implant (silicone or saline) 
 
Other (please explain):  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
 
 
 
C5. Did you have a mastectomy on both breasts?  
  
Yes No 
 
 
 
 
  
           
 
C6. How important were the following factors in your decision to have a mastectomy on both breasts? 
 
Not at all 
important 
A little 
important 
Somewhat 
important 
Quite 
important 
Very 
important 
a. My age 
     
 
b. Having a family history of breast cancer 
     
 
c. Wanting both breasts to match after 
reconstruction  
    
 
 
 
 
Please go to C7 at the 
top of the next page 
 
Please continue to C7 on the next page 
Go to C6 
below 
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C7.  Breast cancer sometimes spreads to the lymph nodes under the armpit.  Which of the following best 
describes what was done to the lymph nodes under your armpit?  Please mark ONE. 
 I did not have any lymph nodes removed 
 
I had a sentinel node biopsy ONLY – where a radioactive material or blue dye was injected into the 
breast and only one or a few lymph nodes in the armpit were removed 
  I had a complete axillary dissection – where all or most of the lymph nodes were removed 
 
  
 
 
 
 
 
I don’t know  
 
Radiation Therapy 
 
 
 
C8.  At the time of your breast cancer diagnosis, how much time did it or would it have taken you to get 
from your home to the nearest radiation treatment facility?   
 
Less than 15 minutes 
 
31 to 60 minutes 
 
 
I don’t know  
15 to 30 minutes 
 
 
More than 60 minutes 
 
 
C9. Did any doctor tell you that radiation treatment… 
 Yes        No Don’t remember 
a. Usually involves daily trips to an outpatient facility 
   
b. Can be completed in 3-4 weeks or less 
   
 
A.  How were all or most of the lymph nodes removed? Please mark ONE. 
I had a needle biopsy before my surgery that showed cancer in the lymph 
nodes under the armpit, so all of the lymph nodes were taken out later 
during my surgery 
I had a single operation in which my sentinel nodes were tested and found 
to have cancer, so all of the lymph nodes were taken out at that time 
I had a single operation in which all of my lymph nodes were removed – 
no needle biopsy or sentinel node testing was done 
My sentinel nodes were found to have cancer during a first operation, so I 
had a second, separate operation to remove all of the lymph nodes 
I’m not sure how the lymph nodes were removed 
Please answer the following questions even if you did not have radiation therapy 
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In the past, radiation treatment has almost always involved five or six weeks of daily treatment (Mondays-
Fridays) to the whole breast.  Recently, doctors have started to sometimes use shorter courses of treatment.   
 
 
 
 
 
 
 
 
 
 
C11. Did any doctor tell you that this kind of shorter course of radiation (3-4 weeks) to the whole breast… 
 
     Yes        No Don’t remember 
a. Works as well as 5-6 weeks to the whole breast 
   
b. Is still being studied 
   
c. May lead to a worse cosmetic result 
   
 
 
 
 
 
 
 
 
C12. Did any doctor tell you that this kind of short courses of radiation (1 week or less) to part of the breast… 
 
   Yes        No Don’t remember 
a. Works as well as 5-6 weeks to the whole breast 
   
b. Is still being studied 
   
c. May lead to a worse cosmetic result 
   
 
 
 
 
C13. When deciding about radiation therapy, how much did the treatment length (in other words, the number 
of weeks of visits for radiation) influence your decision? 
     
Not at all A little Somewhat Quite a bit A lot 
 
Please answer the following questions even if you did not have radiation therapy 
 
C10. Did any doctor tell you that a shorter course of radiation 
(3-4 weeks or less) was an option for you? 
 
  Yes        No 
One kind of short course radiation treatment lasts 3-4 weeks and treats the whole breast.                            
(This is called “hypofractionated whole breast radiation”.) 
 
Another option for a short course of radiation lasts 1 week or less and treats only part of the breast.               
(This is called “accelerated partial breast irradiation” or PBI.) 
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C14.  Did you or are you going to have radiation therapy to treat your breast cancer? 
    
Yes – I am finished 
with radiation therapy 
Yes – I am still having 
radiation therapy 
Yes – I plan to have radiation 
therapy but haven’t started yet 
No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C15. How many total weeks of radiation treatments are planned? 
    
1 week 2-4 weeks 5 weeks 6 or more weeks 
 
C16. How was, or will, your radiation treatment be given?  Please mark ALL that apply. 
    
Using beams from 
outside my body 
Using a balloon placed 
inside my breast 
Using needles placed 
into my breast 
I don’t know how my radiation 
treatment was, or will be, given 
 
C17. Which of the following areas were, or will be, treated with radiation?  Please mark ALL that apply. 
    
My whole breast Only the part of the breast 
where my tumor was 
The chest wall, after my 
mastectomy 
The lymph node areas 
 
 
C14a. Why didn’t you, or don’t you, plan to have radiation therapy?          
Please mark ALL that apply. 
My doctor(s) did not discuss it with me 
My doctor(s) said I didn’t need it 
My doctor(s) left it up to me and I chose not to 
I was worried about side effects or complications 
I was worried about the cost 
It would have been too much of a burden on me or my family 
Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Please go to C18 on the next page 
Please go to C14a 
Please go to 
C15 below 
Please continue to C18 on the next page 
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Chemotherapy 
C18. Chemotherapy is a treatment where medicine is given into a vein to try to kill any cancer cells in the body 
that may remain after surgery.   
Did you or are you going to have chemotherapy to treat your breast cancer? 
    
Yes – I am finished 
with chemotherapy 
Yes – I am still getting 
chemotherapy 
Yes – I plan to get chemotherapy 
but haven’t started yet 
No 
 
 
C19. When did you, or will you, have your first dose of chemotherapy? 
 Before I had my surgery (lumpectomy or mastectomy) 
 After I had my surgery 
 N/A – I will not receive any chemotherapy 
 
 
 
Hormonal Therapy 
C20. Hormonal therapy helps block estrogen from getting to cancer cells that may remain in the body. 
Hormonal therapy is sometimes called “anti-estrogen therapy” or “endocrine therapy.” Examples include 
tamoxifen, anastrozole or Arimidex, letrozole or Femara, and exemestane or Aromasin.  
 
Have you or are you going to be taking any of these medications?  Please mark ONE. 
 
 Yes, I currently take one of these medications 
 Yes, I plan to take one of these medications in the future but haven’t started yet 
 Yes, I took one of these medications before but no longer take it  
 No, I am not taking any of these medications right now and I am unsure whether or not I 
should start 
 No, I have no plans to take any of these medications 
 
 
Side Effects During Treatment 
 
C21.  In the past 7 days, I have been bothered by side effects of treatment. 
     
 
Not at all A little bit Somewhat Quite a bit Very much 
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C22. During treatment – including surgery, radiation, and chemotherapy – please tell us how severe each of 
these side effects was at its worst. 
At its worst, what was the severity of your… 
None Mild Moderate Severe Very severe 
a. Nausea and vomiting      
b. Loose or watery stools or diarrhea      
c. Constipation or hard stools      
d. Pain      
e. Arm swelling      
f. Shortness of breath      
g. Breast skin irritation      
h. Fatigue      
i. Feelings of sadness or anxiety      
 
C23.  Next, we would like to know if you got help from your health care team to deal with any side effects of 
treatment – even one time.  Please mark ALL that apply on each row. 
 
I did not have or 
seek help for 
this problem 
I called or 
emailed for 
help 
I discussed it 
at a routine 
clinic visit 
I went for an 
unscheduled  
clinic visit 
I went to the 
emergency 
room or hospital 
a. Nausea and vomiting      
b. Loose or watery stools 
or diarrhea 
 
    
c. Constipation or hard 
stools 
 
  
 
 
d. Pain    
 
 
e. Arm swelling      
f. Shortness of breath    
 
 
g. Breast skin irritation    
 
 
h. Fatigue      
i. Feelings of sadness or 
anxiety 
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Section D:  Decision Making 
D1. In general, please tell us how often you have these thoughts and feelings when you make decisions. 
 Never Rarely Sometimes Often Always 
a. I worry about making a bad decision 
     
b. I struggle to decide what the right decision is 
     
c. I get angry at myself when I have made a bad 
decision 
     
d. I worry a lot about the outcomes of my decisions 
     
 
D2.  When making decisions about how to treat my breast cancer… 
 Not     
at all  A little Somewhat 
Quite    
a bit A lot 
a. I weighed the pros and cons of all the treatment options 
     
b. I feel like I really thought through all the issues 
important to the treatment decisions 
    
 
c. I talked with others – family or friends – before making 
treatment decisions 
    
 
d. I talked with other breast cancer patients before making 
treatment decisions 
    
 
e. I spent time thinking about all of the treatment options 
    
 
 
 
D3.  When making decisions about how to treat my breast cancer… 
 Not at 
all 
A little 
bit Somewhat 
Quite  
a bit 
Very 
much 
a. I would like to have had more information 
     
b. I would like to have participated more 
     
c. I am satisfied with the amount of time I had 
     
d. I am satisfied with the amount of involvement I had 
from family and friends  
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D4. When decisions were being made about your treatments, how important was it to you 
that your treatments…   
 
Not at all 
important 
A little 
important 
Somewhat 
important 
Quite 
important 
Very 
important 
a. Reduced the need for more surgery 
     
b. Allowed you to avoid side effects of treatment 
     
c.  Allowed you to avoid exposure to radiation 
     
d. Required fewer trips back and forth for 
treatment visits 
     
e. Did not make you feel bad about your body 
     
f. Kept you from worrying about the cancer 
coming back 
     
g. Allowed you to feel feminine 
     
h. Were the most extensive possible 
     
i. Were the least extensive possible 
     
j. Allowed you to keep your original breast 
     
k. Were what your partner/family wanted you to do 
    
l. Were what your doctor wanted you to do  
     
m. Were the same treatments that other women 
you know have received 
     
n. Were the newest, most advanced treatments 
available  
     
o. Had the shortest recovery time 
     
p. Gave you peace of mind 
     
q. Allowed you to avoid having follow-up 
mammograms 
     
r. Did not require you to spend a lot of your own 
money 
     
s. Had a lower possibility of complications 
     
t. Allowed you to continue to care for your home 
and family 
     
u. Allowed you to continue to work for pay  
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D5. At the time that decisions were being made about your treatments, how much do you feel that                
your preferences were considered?  
   
  
 
Not at all Slightly Moderately Very much Completely 
 
Surgery decisions 
D6.  When did you make a decision about your initial surgical treatment? 
   Before my first visit with a surgeon 
   After my first visit with a surgeon 
   After two or more visits 
 
D7.  Did you see a second surgeon for an opinion about your surgery treatment options? 
    Yes      
 
 
   No             
   
 
D8.  How strongly did the surgeons you consulted for breast cancer recommend one option over the other for 
your initial surgery?  
     
 
Strongly 
recommended 
lumpectomy 
Weakly 
recommended 
lumpectomy 
Did not recommend 
one surgery option 
over the other 
Weakly 
recommended 
mastectomy 
Strongly 
recommended 
mastectomy 
 
 
D9. How strongly did you consider having a mastectomy on both breasts?  
     
 
Very strongly Strongly Moderately Weakly Not at all 
 
 
D10. When you discussed treatment options with your surgeon, was the idea of having a mastectomy on both 
breasts ever discussed?    Please mark ONE. 
 
     No, it was never discussed 
 
     Yes, and I was the first to bring it up 
 
     Yes, and my surgeon was the first to bring it up 
 
     Yes, and another person I brought to my clinic visit was the first to bring it up 
a. Did that second surgeon perform your breast surgery? 
   Yes              No            
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D11. How much time did you spend talking with the surgeons you consulted for breast cancer about having      
a mastectomy on both breasts? 
     
 
No time       
at all 
A little bit          
of time 
Some    
time 
Quite a lot          
of time 
All of the time                                      
(it was the only option we talked about) 
 
 
D12. How strongly did the surgeons you consulted for breast cancer recommend having a mastectomy on both 
breasts? 
     
 
Strongly 
recommended it 
Weakly 
recommended it 
Did not make a 
recommendation – 
left it up to me 
Weakly 
recommended 
against it 
Strongly 
recommended 
against it 
 
 
D13.  How much did the surgeons you consulted for breast cancer oppose your interest in having a  
mastectomy on both breasts? 
      
Not at all A little bit Somewhat Quite a bit Very much I did not have any interest in having a 
mastectomy on both breasts 
 
 
 
D14. My surgeons told me that having a mastectomy on my “other” breast – the breast without cancer – 
would: 
 
 Yes No Not discussed 
a. Give me a better chance of surviving the breast 
cancer I already have 
  
 
b. Reduce the chances of the breast cancer I 
already have coming back 
  
 
c. Reduce the chances of developing a new 
cancer in my “other” breast   
 
d. Improve the cosmetic outcome of my surgery   
 
e. Make my recovery from the surgery take longer   
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Chemotherapy decisions 
 
A medical oncologist is a doctor that specializes in discussing and giving chemotherapy and hormonal therapy, 
when needed, to women with breast cancer. 
D15. Did you see a medical oncologist to talk about whether or not to receive chemotherapy?   
   
Yes   No Don’t know 
 
 
D16.  How strongly did the first medical oncologist you consulted recommend chemotherapy? 
      
Very strongly 
recommended it 
Weakly 
recommended it 
Left it up to me Weakly 
recommended 
against it 
Very strongly 
recommended 
against it 
I did not consult 
with a  medical 
oncologist 
 
 
 
Section E:  How You Feel About Your Decisions 
 
Please tell us how you feel about the decisions that were made for your breast cancer treatment.  If your doctor 
did not offer you the test or treatment that is listed, please mark N/A for “Not applicable.” 
 
 
E1. Please rate the amount of information you had when the following decisions were made: 
 
Not 
enough  
Just  
right  
Too 
much N/A 
a. Whether or not to have a breast MRI 
      
b. Whether or not to have your tumor sent 
for the Oncotype DX test 
      
c. Whether or not to have a BRCA test to 
see if you have the gene for breast cancer 
 
     
d. Which type of surgery to have 
      
e. Whether or not to have radiation therapy 
      
f. Whether or not to have chemotherapy 
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E2. I received enough information about the following topics: 
 
Strongly 
Agree Agree 
Neither agree 
nor disagree Disagree 
Strongly 
Disagree 
a. The effects of breast cancer and treatment 
on sexual functioning 
     
b. The impact of treatment on ability to work 
inside or outside the home 
  
   
c. The effects of having breast cancer on my 
relationships with family and friends 
  
   
d. The risk of my breast cancer coming back 
  
   
e. How to deal with feelings of anxiety or 
depression 
  
   
 
 
 
 
E3. How satisfied are you with the decision about… 
 
Not at all 
satisfied 
A little 
satisfied 
Somewhat 
satisfied 
Quite 
satisfied 
Totally 
satisfied N/A 
a. Whether or not to have a breast MRI 
      
b. Whether or not to have your tumor sent 
for the Oncotype DX test 
      
c. Whether or not to have a BRCA test to 
see if you have the gene for breast cancer 
      
d. Which type of surgery to have 
      
e. Whether or not to have radiation therapy 
      
f. Whether or not to have chemotherapy 
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Section F: Questions about Breast Cancer 
 
Please answer the following questions about the tests and treatments for breast cancer. 
 
 
F1. Which treatment gives women a better chance of surviving breast cancer?  
      Lumpectomy with radiation 
 
      Mastectomy 
 
      There is no difference between these two treatment options 
 
      Don’t know  
 
F2. On average, which treatment results in a higher chance of the cancer coming back anywhere in the body 
after being treated? 
      Lumpectomy with radiation 
 
      Mastectomy 
 
      There is no difference between these two treatment options 
 
      Don’t know  
 
F3. Does removing the “other” breast – the breast without cancer – improve survival for … 
 Yes No Don’t know 
a. All women with breast cancer   
 
b. Women with a strong family history of breast cancer    
c. Women with a genetic mutation that increases cancer risk   
 
 
F4. If any breast cancer cells are found under the arm, do all lymph nodes under the arm need to be removed? 
   
Yes No Don’t know 
 
F5. Does removing all the lymph nodes under your arm increase the risk of arm swelling? 
   
Yes No Don’t know 
 
F6.  Is it possible that your breast cancer will spread to other parts of your body?   
   
Yes No Don’t know 
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Section G:  Support from Others  
The information below will allow us to better understand how family and friends help breast cancer patients with 
treatment decisions and will provide us with ideas on how to offer more support in the future. 
G1. When decisions were being made about your treatments for your breast cancer, who were the most 
important people who helped you with those decisions?  
Please print the initials 
of up to 3 people who 
were involved in your 
decision making and 
their relationship to you 
(e.g. family, friend, 
other) 
How important was this 
person’s opinion in your 
treatment decision making?    
Please circle ONE option 
where 1 is not at all 
important and 5 is very 
important. 
How satisfied were you with 
how involved this person 
was? 
Please circle ONE option 
where 1 is not at all 
satisfied and 5 is very 
satisfied. 
Which treatment 
decision(s) was this 
person involved in? 
Please mark ALL 
that apply. 
EXAMPLE   
L.W., Daughter 
EXAMPLE 
1         2        3       4       5 
Not at all                                      Very 
Important                            Important 
EXAMPLE 
1         2        3       4       5 
Not at all                                      Very 
Satisfied                               Satisfied 
EXAMPLE 
     Which surgery to have     
     Whether or not to 
have radiation therapy    
     Whether or not to 
have chemotherapy 
1. 
1       2       3       4       5 1       2       3       4       5 
     
     Which surgery to have     
     Whether or not to 
have radiation therapy    
     Whether or not to 
have chemotherapy 
2. 
1       2       3       4       5 1       2       3       4       5 
     
     Which surgery to have     
     Whether or not to 
have radiation therapy    
     Whether or not to 
have chemotherapy 
3. 
1       2       3       4       5 1       2       3       4       5 
     
     Which surgery to have     
     Whether or not to 
have radiation therapy    
     Whether or not to 
have chemotherapy 
 
 
 
 
 
 
 
 
3 3 
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G2.  Thinking about the family and friends who helped you with your treatment decisions, how often did one of 
these people… 
 Never Rarely   Sometimes   Often Very often 
a. Attend doctor appointments with you where decisions 
about your treatment plan were discussed  
     
b. Take notes for you during a doctor’s appointment 
  
 
 
 
c. Talk to you about your treatment options 
  
 
 
 
d. Share information with you from other sources about 
your treatment options (for example, from the internet 
or from talking with others)  
  
 
 
 
 
Section H: Communicating with Your Doctors 
 
None of 
the time 
A little of 
the time 
Some of 
the time 
Quite a bit 
of the time 
All of  
the time 
H1. When it came to getting treatment for breast 
cancer, I preferred to be told what to do 
 
    
H2. When it came to getting treatment for breast              
cancer, I wanted my doctor to tell me what to do     
H3. I preferred to make my own decisions about my 
treatments for breast cancer 
 
  
  
 
 
 
H4. For the next set of questions, please think about the surgeon who was most involved in your surgery.  
I feel that my surgeon… 
 
Not at  
all true 
A little 
true 
Somewhat 
true 
Quite 
true 
Very 
true 
a. Understood how I saw things with respect to 
my breast cancer 
    
 
b. Listened to how I would like to handle my 
breast cancer treatment 
     
c. Encouraged me to ask questions     
 
 
H5. How often did your surgeons or their staff help you with referrals to other cancer doctors for treatments 
such as radiation or chemotherapy? 
     
 
Never Rarely Sometimes Usually Always 
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H6. These next questions are about the medical oncologist who was most involved in the decision about 
whether or not you had or plan to have chemotherapy.   
                    
 
I feel that my medical oncologist… 
 
Not at  
all true 
A little 
true 
Somewhat 
true 
Quite 
true 
Very 
true 
a. Understood how I saw things with respect to 
my breast cancer 
 
 
   
b. Listened to how I would like to handle my 
breast cancer treatment 
    
 
c. Encouraged me to ask questions     
 
 
 
These next questions are about your primary care provider - the health care provider that you see for general 
illnesses or routine checkups. 
H7. How long have you been seeing your current primary care provider? 
     
Less than               
6 months 
6 – 11 months 1 – 2 years More than 2 
years 
I don’t currently have a 
primary care provider 
 
 
H8. Since your breast cancer diagnosis, how many times have you seen your current primary care provider? 
    
I haven’t seen my primary care 
provider since my diagnosis 
1 time 2 times 3 or more times 
 
 
 
H9. In general, I feel that my current primary care provider… 
 
Not at  
all true 
A little 
true 
Somewhat 
true 
Quite 
true 
Very 
true 
a. Understands how I see things with respect to 
my medical care 
 
 
   
b. Listens to how I would like to handle things 
regarding my medical care 
    
 
c. Encourages me to ask questions     
 
 
 
If you did not see a medical oncologist, 
please go to H7 below 
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H10. Please read each statement and mark ONE response on each row. 
 Never Rarely Sometimes Often Always 
a. When you have a new health problem, do you go to your 
primary care provider before going somewhere else? 
     
b.  Does your primary care provider know what problems 
are most important to you? 
  
 
  
c. After going to th  specialist or special service for breast 
cancer, did your primary care provider talk with you 
about what happened at the visit? 
  
 
  
 
H11. How much did your primary care provider participate in your breast cancer treatment decisions?  
     
Not at all A little bit Somewhat Quite a bit A lot 
 
 
H12. In the past 6 months, how often did your primary care provider seem informed and up-to-date about the  
       care you got from your breast cancer doctors? 
     
Never Rarely Sometimes Often Always 
 
 
H13. After your initial cancer treatment is finished, which doctor would you prefer to see for each of the 
following?      
 
Prefer 
primary care 
provider 
Prefer 
cancer 
doctors 
Either one 
is fine 
Prefer to 
see both 
a. Follow-up for breast cancer (mammograms)  
    
b. Screening for other cancers   
  
c. General preventive care such as vaccinations 
or check-ups 
  
  
d. Treatment of my ongoing or future medical 
problems such as diabetes or heart disease 
  
  
e. Physical symptoms such as pain, fatigue, or 
lymphedema 
  
  
f. Emotional problems such as depression or 
anxiety 
  
  
g. Reassuring me about my breast cancer   
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H14. During your breast cancer care, how satisfied were you with how your doctors worked together?  
     
Not at all     
satisfied 
A little        
satisfied 
Somewhat     
satisfied 
Very          
satisfied 
Extremely        
satisfied 
 
 
H15. How frequently has one of your cancer doctors (not your primary care provider) done any of the following?  
 Never Rarely Sometimes Often A lot 
a. Written a prescription for a problem other than 
your breast can er 
     
b. Given you a referral to another specialist for 
something not related to your breast cancer 
 
 
   
c. Ordered a test for something other than your 
breast cancer care 
 
 
   
 
 
 
 
Section I: Your Thoughts and Feelings 
The questions below are important to help us better understand how women like you feel towards the end of 
treatment and the beginning of the recovery period.  Please answer these questions the best way you can. 
I1. For the question below, please write in a number from 0% to 100% where… 
     0% = you think there is absolutely no chance that your breast cancer will 
come back in the breast or the area around it in the next 10 years, and 
 
100% = you think it is absolutely certain that your breast cancer will 
come back in the breast or the area around it in the next 10 years 
 
After receiving all the planned treatments, what do you think is the chance that your cancer will come back 
in the breast or the area around it within 10 years? 
 
 
 
I2. After receiving all of the planned treatments, do you consider the chance of your cancer coming back in the 
breast or the area around it to be: 
     
Very low Low Moderate High Very high 
 
 
________ % (0 to 100) 
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I3.  Next, we would like to ask you for your opinion on the chances of your cancer spreading to other parts of 
your body. For the question below, please write in a number from 0% to 100% where… 
    0% = you think there is absolutely no chance that your breast cancer will 
spread to other parts of your body in the next 10 years, and 
 
100% = you think it is absolutely certain that your breast cancer will  
             spread to other parts of your body in the next 10 years 
 
After receiving all the planned treatments, what do you think is the chance that your cancer will           
spread to other parts of your body within 10 years? 
 
 
 
I3a. Why did you pick this number? 
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________ 
 
 
I4. After receiving all the planned treatments, do you consider the chance of your cancer spreading to other 
parts of your body to be: 
     
Very low Low Moderate High Very high 
 
 
I5. How much did your doctors discuss with you the chance of your cancer coming back?  
     
Not at all A little bit Somewhat Quite a bit A lot 
 
 
I6. When your doctors discussed the chance of your cancer coming back, did they use… 
    
Only words 
(For example, “small chance”) 
Only numbers 
(For example, “8% chance”) 
Both words 
and numbers 
My doctors did not   
discuss the risk with me 
 
 
 
I7.  Compared to other women with similar breast cancer and treatment, how likely do you think it is that your 
breast cancer will come back? 
     
Much less likely Less likely About the same More likely Much more likely 
 
 
________ % (0 to 100) 
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I8.  In the past month, how often have you worried about your cancer coming back?  
     
Almost never Rarely Sometimes Often Almost always 
 
I9.  During the past month, how often has worrying about your cancer coming back… 
 Almost 
never Rarely Sometimes Often 
Almost 
always 
a. Made you feel upset?  
  
  
b. Made it difficult for you to carry out your usual 
daily activities at home or at work? 
  
 
  
c. Made you feel distant from family and friends?  
  
  
 
I10.  When you see your cancer doctors for follow-up care, how often do they ask if you are worried about your 
breast cancer coming back? 
     
Almost never Rarely Sometimes Often Almost always 
 
Section J – Family History of Cancer 
To help us better understand your family history, please answer the following question to tell us if any of your 
blood relatives have had breast cancer and how old they were at the time of their breast cancer diagnosis. 
J1.  Has your mother ever been diagnosed with breast cancer? 
             Yes, my mother was diagnosed with breast cancer before age 50 
  
             Yes, my mother was diagnosed with breast cancer at or after age 50 
   
             No 
 
             Don’t know 
 
Sisters      
J2. How many sisters do you have? 
       
     0 
       
     1 
       
     2 
       
     3 
       
     4 or more 
J3. How many of your sisters have been diagnosed 
with breast cancer? 
     0      1      2      3 
       
     
     4 or more 
J4. Have any of your sisters been diagnosed with 
breast cancer before age 50? 
 
      Yes             
 
      No             
 
      Don’t know           
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Daughters      
J5. How many daughters do you have? 
       
     0 
       
     1 
       
     2 
       
     3 
       
     4 or more 
J6. How many of your daughters have been 
diagnosed with breast cancer? 
     0      1      2      3 
       
      
     4 or more 
J7. Have any of your daughters been diagnosed with 
breast cancer b fore age 50? 
 
      Yes             
 
      No             
 
      Don’t know           
 
 
J8.  Although it is uncommon, men can also get breast cancer.  Has a man in your family (blood relative) ever 
been diagnosed with breast cancer? 
   
Yes No Don’t know 
 
 
J9.  Have any of your parents, brothers, sisters, or biological (blood related) children ever been diagnosed with  
       any of the cancers below?  Please mark ALL that apply. 
     Ovarian                
cancer 
Uterine                
cancer 
  Prostate                
cancer 
     Colon cancer      Stomach (gastric)                
cancer 
     Pancreatic                
cancer 
Brain                
cancer 
     Sarcoma   
(muscle or bone)                 
     Ocular   
melanoma (eye)                 
     Cutaneous 
melanoma (skin)                 
     Leukemia 
(blood)                 
     None of these                 
 
 
 
J10. Has your spouse or partner ever been diagnosed with any type of cancer? 
   
Yes No I don’t have a spouse or partner 
 
 
 
 
Section K:  Home and Work 
Before Your Breast Cancer Diagnosis 
 
K1. Before you were diagnosed with breast cancer, did you work for pay? 
 
 
K2.  Before you were diagnosed with breast cancer, what was your employment status?  
Please mark ALL that apply. 
 
     Employed full-time 
 
     Retired 
 
     Employed part-time 
 
     Student 
 
     Unemployed and looking for work 
 
     Homemaker 
 
     Temporarily laid off or on sick or other leave 
 
     Other (please explain): _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
     Disabled 
 
Yes            No 
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K3. On average, about how many hours per week did you work before your diagnosis?   
 
 
 
 
K4. At the time of your breast cancer diagnosis, which of the following was available to you through your 
employer?  Please mark ALL that apply. 
             I did not work for pay at the time of my diagnosis with breast cancer 
  
             Paid sick leave 
   
             Disability benefits 
 
             Flexible work schedule 
 
             None of the above 
 
             Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
 
 
 
K5.  At the time of your breast cancer diagnosis, what was the total yearly income of your entire 
household, before taxes, from all sources – including child support, alimony, disability, social security, 
and unemployment?   
 
     Less than $5,000 
 
     $40,000-$59,999 
 
     $5,000-$9,999 
 
     $60,000-$89,999 
 
     $10,000-$19,999 
 
     $90,000 or more 
 
     $20,000-$29,999 
 
     Don’t know 
 
     $30,000-$39,999 
 
 
K6.  At the time of your breast cancer diagnosis, how many people were supported by the total income 
for your household, including yourself? 
 
       1 (just you) 
 
       2 people 
 
       3 people 
 
       4 or more people 
 
 
During Your Treatment for Breast Cancer 
 
 
K7. Did you work for pay during any of your breast cancer treatment?    
 
 
 
K8. About how many days of work have you missed because of your breast cancer or its treatment? 
 
     I haven’t missed any work 
 
     15 – 30 days 
 
     Less than a week 
 
     More than a month 
 
     7 – 14 days 
 
     I stopped working all together 
 
______ hours per week 
 
Yes            No 
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K9. Since your breast cancer diagnosis, how much money (income) have you lost due to time off from work?  
 
     $0 
 
     $2,001 to $5,000 
 
     $1 to $500 
 
     $5,001 to $10,000 
 
     $501 to $2,000 
 
     More than $10,000 
 
 
K10. How much have you paid out-of-pocket for medical expenses related to your breast cancer           
(including co-payments, hospital bills, and medication costs)?   
 
     $0 
 
     $2,001 to $5,000 
 
     $1 to $500 
 
     $5,001 to $10,000 
 
     $501 to $2,000 
 
     More than $10,000 
 
K11. How much money have you spent over and above your normal budget due to out-of-pocket                  
non-medical expenses related to your breast cancer (such as supplies like wigs, bras, or             
bandages; travel; child or elder care; and complementary or alternative medicine)?   
 
     $0 
 
     $2,001 to $5,000 
 
     $1 to $500 
 
     $5,001 to $10,000 
 
     $501 to $2,000 
 
     More than $10,000 
 
 
K12. Do you currently have debt (for example, unpaid bills, credit card balance, bank loans, or borrowing money 
from family or friends) from your breast cancer treatment?   
 
 
 
K13. Due to the financial impact of having breast cancer… 
     Yes      No  
 
 a. I had to use savings 
 
 b. I could not make payments on credit cards or other bills 
 
 c. I cut down on spending for food 
 
 d. I had my utilities turned off because the bill was not paid 
 
 e. I had to move out of my house or apartment because I could not afford to stay there 
 
 f. Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
  
Yes No 
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Since your breast cancer diagnosis, are you worse off regarding… 
K14. Employment status?      
 
   No             
 
   Yes             
 
 
 
K15. Financial status?      
 
   No             
 
   Yes             
 
 
 
 
K16. How much do you worry about current or future financial problems as a result of your breast cancer       
and treatments? 
     
Not at all A little Somewhat Quite a bit A lot 
 
 
K17. How much did you want to talk to your health care providers about the impact of having breast cancer   
on your employment or finances? 
     
Not at all A little Somewhat Quite a bit A lot 
 
 
K18. During your breast cancer experience, how much did you discuss the impact of having breast cancer 
on your employment or finances with each of the following people? 
 Not at all A little bit Somewhat Quite a bit A lot 
a. Cancer doctors      
b. Social worker or other professional      
c. Primary care doctor      
 
K19. How much did your cancer doctors and their staff help you in dealing with the impact of having breast 
cancer on your employment or finances?   
     
Not at all A little Somewhat Quite a bit A lot 
a. How much is this due to your breast cancer and treatment? 
 
   Not at all      A little      Somewhat      Quite a bit      Very much 
a. How much is this due to your breast cancer and treatment? 
 
   Not at all      A little      Somewhat      Quite a bit      Very much 
Page 66 of 76Cancer
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
33 
 
 
Current Status 
K20. Are you currently working for pay?             
 
 
K21. Which of the following best describes your current employment status? Please mark ALL that apply. 
 
     Employed full-time 
 
     Retired 
 
     Employed part-time 
 
     Student 
 
     Unemployed and looking for work 
 
     Homemaker 
 
     Temporarily laid off or on sick or other leave 
 
     Other (please explain): _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
     Disabled 
 
K22. Please tell us about your medical insurance right before you were diagnosed with breast cancer as well as 
your medical insurance at the present time.  Please mark ALL that apply in both columns. 
What type of medical insurance…        
 
Did you have right 
before your breast 
cancer diagnosis? Do you currently have? 
a. None 
  
b. Insurance provided through my current or former 
employer or union (including HMO) 
  
c. Insurance provided to another family member (e.g., 
spouse) through their current or former employer or 
union (including HMO) 
  
d. Insurance purchased directly from an insurance 
company (by you or another family member) 
  
e. Insurance purchased from an exchange (sometimes 
called “Obamacare” or the Affordable Care Act) 
  
f. Medicaid or other state provided insurance   
g. Medicare/government insurance   
h. Veterans Affairs (VA, including those who have ever 
used or enrolled for VA health care) 
  
i. Other (please explain): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
  
 
K23. In the last 12 months, have the costs of your prescription medicine(s) been covered by health insurance?    
     
Completely 
covered 
Mostly covered Partly covered Not covered at all I have not taken any prescription 
medicine in the past 12 months 
 
Yes            No 
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Section L: Language and Other Preferences 
L1.  What language do you primarily speak?  Please mark ONE. 
     English      Mandarin      Cantonese      Korean 
     Spanish      Vietnamese      Japanese                 Other (please explain): _ _ _ _ _ _ _ _ _ 
    
 
L2. In general, what language(s) do you read and speak? 
     
Only English English better than 
any other language 
Both equally Another language 
better than English 
Only another 
language 
 
L3. What language do you usually speak at home? 
     
Only English More English than 
any other language 
Both equally Another language 
more than English 
Only another 
language 
 
L4. In what language do you usually think? 
     
Only English More English than 
any other language 
Both equally Another language 
more than English 
Only another 
language 
 
L5. What language do you usually speak with your friends? 
     
Only English More English than 
any other language 
Both equally Another language 
more than English 
Only another 
language 
 
L6. Please circle the ONE number on each line that best describes your thoughts and feelings.  
All things considered, I feel that I… 
 
a. 1              2              3              4              5              6              7              8              9              10 
   Am lucky                                                                                                                                Am unlucky 
      in life                                                                                                                                         in life 
 
 
 
b. 1              2              3              4              5              6              7              8              9              10 
    Almost                                                                                                                                      Almost 
never worry                                                                                                                             always worry 
 
 
 
c. 1              2              3              4              5              6              7              8              9              10 
    Am very                                                                                                                                   Am very 
   optimistic                                                                                                                                pessimistic 
   about life                                                                                                                                  about life 
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L7. How much do you agree with each of the items below?  
 Not at all A little bit Somewhat Quite a bit A lot 
a. Through my faith in God, I can stay healthy 
 
 
   
b. I rely on God to keep me in good health      
c. Prayer is the most important thing I do to 
stay healthy 
     
 
L8. How often do you have someone help you when you read instructions, pamphlets, or other written material 
from your doctor or pharmacy? 
     
Never Rarely Sometimes Often Always 
 
L9. How often do you find numerical information to be useful?    
     
Never Rarely Sometimes Often Very often 
 
 
Section M:  A Few More Questions 
 
M1.  Today’s date is:    
 
 
 
M2. About how tall are you?   
 
 
 
M3. At the time of your breast cancer diagnosis, about how much did you weigh? 
 
 
 
 
M4. Before your breast surgery, what was your bra cup size? 
 
     A 
 
     D 
 
     B 
 
     DD 
 
     C 
 
     Other (please explain): _ _ _ _ _ _ _ _ _ _ 
 
_____feet  _____inches     or     _____meters 
 
_______pounds     or     _______kilograms 
 
 
______ / _______ / ________ 
month        day           year 
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M5. In the 12 months before your diagnosis with breast cancer, what was your experience with your 
menstrual periods? 
 
     I had no menstrual periods in the 12 months before my breast cancer diagnosis 
 
     I had regular (or the usual timing of) menstrual periods in the 12 months before my breast cancer 
diagnosis 
 
     I had a change in the timing of menstrual periods in the 12 months before my breast cancer diagnosis 
 
 
M6. In the 12 months before your breast cancer diagnosis, did you experience hot flashes or night sweats 
at any time – even once? 
  
Yes No 
 
 
M7. What is your birth date?     
 
 
 
M8. When you were diagnosed with breast cancer, what was your marital status? 
 
     Married 
 
     Living with partner 
 
     Divorced 
 
     Widowed 
 
     Separated 
 
     Never married 
 
 
M9.  What is the highest level of education you have completed? 
 
     No high school 
 
     Some college or technical school 
 
     Some high school 
 
     College graduate (Bachelor’s degree) 
 
     High school graduate or G.E.D. 
 
     Graduate degree or higher 
 
M10.  Are you of Hispanic, Latino, or Spanish origin? 
 
     Yes, Mexican, Mexican-American, or Chicano 
 
     Yes, Puerto Rican 
 
     Yes, Cuban 
 
     Yes, another Hispanic, Latino, or Spanish origin (please explain):  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
     No 
 
 
 
 
_______ / ________ / ____________ 
 month          day                year 
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M11.  Are you of Jewish descent?    
   
Yes No Don’t know 
 
 
 
 
M12.  For how many years have you lived in the United States?      
 
 
 
 
 
M13.  In what country were you born?  
               Don’t know 
 
 
 
M14.  In what country was your mother born?                 
               Don’t know 
 
 
 
M15. In what country was your father born?  
               Don’t know 
 
 
 
 
 
 
M16.  Which of the following best describes your race?  Please mark ALL that apply. 
 
     White 
 
     Chinese 
 
     Black or African-American  
 
     Filipino 
 
     American Indian or Alaska Native  
 
     Japanese 
 
     Native Hawaiian or other Pacific Islander  
 
     Korean 
 
     Asian Indian 
 
     Vietnamese 
 
     Other Asian (please explain):  _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
     Other Race (please explain): _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
 
 
 
 
______ years 
 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ 
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Section N:  Your Doctors 
N1. We want to learn from doctors about better ways to communicate with patients and their families about 
treatment decisions. The information you provide below will help us contact the doctors who treat patients 
with breast cancer.  The doctors may be surveyed about their treatment practices.  Importantly, your 
answers will never be shared with any doctors and your personal information including your name will 
never be used in any communication. 
a. Surgeon who performed your first lumpectomy or mastectomy: 
Doctor’s last name:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  First name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Name of hospital or clinic:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
City: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
b. Medical oncologist who talked to you about or delivered chemotherapy or hormonal therapy: 
Doctor’s last name:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  First name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Name of hospital or clinic:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
City: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
c. Clinic or hospital where you received most of your chemotherapy:   
Name of clinic or hospital: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Street address:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _     City:_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
d. Radiation oncologist who talked to you about or delivered radiation therapy: 
Doctor’s last name:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  First name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Name of hospital or clinic:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
City: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
e. Plastic surgeon or breast surgeon who performed your breast reconstruction: 
Doctor’s last name:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  First name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Name of hospital or clinic:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
City: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
f. Primary Care Provider (or family doctor) who sees you for general illnesses or routine checkups: 
Doctor’s last name:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  First name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Name of hospital or clinic:  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
City: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
Please continue to the next page 
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N2. We were recently funded by the American Cancer Society to study how family and friends help patients 
with their treatment decisions. It’s important to hear directly from family and friends about their experiences. 
This study will help find ways to improve decision support for patients, family, and friends in the future.   
As a part of this new study, we would like to send a short survey to the one person (family or friend) age 21 
or older who was most involved in helping you with your treatment decisions.  All information collected 
from that person will remain confidential.  Also, your survey responses will never be shared with your family 
or friends.   
 
Please tell us how you would like for us to send the survey: 
 
 
     Please mail the survey packet to this person directly: 
 
     Please mail the survey packet to me and I will give it to this person 
 
     I would like more information 
 
 
 
 
Thank you very much for filling out this survey! Your answers are very important to us. 
_________________________________ 
First name                           Last name 
_________________________________ 
Address 
____________________________________ 
Address line 2 (if needed) 
____________________________________ 
City                                State     Zip code 
(_________)__________________________ 
This person’s 10-digit phone number 
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Supplemental Material 
 
Supplementary Table 1: Amount of missed work by selected patient characteristics (bivariable 
analyses) 
 
  
 Zero 
to 30 
days 
missed 
More 
than 
30 
days 
missed 
Stopped 
working 
P 
value 
Age at Diagnosis       <.001 
50 or less 40% 44% 16%   
51-65 53% 31% 16%   
66-79 57% 21% 22%   
Stage       <.001 
0 58% 34% 8%   
I 51% 35% 14%   
II 35% 32% 33%   
Any Co-Morbidities       0.352 
No 49% 35% 16%   
Yes 50% 30% 20%   
Health Status       <.001 
Poor 0% 20% 80%   
Fair 32% 32% 37%   
Good 41% 37% 22%   
Very Good 58% 33% 9%   
Excellent 60% 30% 9%   
Chemotherapy       <.001 
No chemotherapy 57% 34% 9%   
Chemotherapy 31% 34% 35%   
Radiotherapy       <.001 
No radiotherapy 37% 44% 20%   
Radiotherapy 60% 26% 14%   
Surgical Treatment       <.001 
Lumpectomy (ref) 63% 23% 14%   
Unilateral mastectomy without reconstruction 19% 41% 40%  
Unilateral mastectomy with reconstruction 26% 49% 25%  
Bilateral mastectomy without reconstruction 31% 36% 32%  
Bilateral mastectomy with reconstruction 27% 61% 12%  
Axillary Lymph Node Dissection       <.001 
No ALND 49% 35% 15%   
ALND 45% 22% 33%   
Race       <.001 
    Non-Hispanic White 58% 30% 12%   
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 Zero 
to 30 
days 
missed 
More 
than 
30 
days 
missed 
Stopped 
working 
P 
value 
    Non-Hispanic Black 35% 45% 20%   
    Latina 37% 36% 27%   
Non-Hispanic Asian 45% 36% 19%   
Other 57% 18% 25%   
Education       <.001 
High school or less 39% 34% 27%   
Some college or technical school 50% 33% 18%   
    College graduate or more 53% 35% 12%   
Marital Status       0.042 
Not partnered 47% 32% 21%   
Married/partnered 50% 35% 15%   
Site       0.115 
Georgia 52% 33% 15%   
Los Angeles 46% 35% 19%   
Employment Status       0.039 
Part Time 53% 26% 21%   
Full Time 48% 36% 16%   
Work Hours/Week       0.011 
1-35 hrs/week 52% 25% 22%   
36-44 hrs/week 48% 37% 14%   
    45+ hrs/week 48% 37% 15%   
Paid Sick Leave       <.001 
No 47% 28% 25%   
Yes 51% 40% 9%   
Disability Benefits    <.001 
No 58% 26% 17%   
Yes 35% 47% 17%   
Flexible Work Schedule       <.001 
    No 39% 38% 23%   
Yes 65% 28% 7%   
Household Income       <.001 
    <$40,000 35% 33% 32%   
$40,000 - $89,999 53% 35% 12%   
$90,000 + 55% 34% 11%   
People Supported by Household Income       <.001 
1 (Self only) 50% 28% 21%   
2 54% 32% 14%   
3 40% 35% 25%   
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 Zero 
to 30 
days 
missed 
More 
than 
30 
days 
missed 
Stopped 
working 
P 
value 
    4 Or More 45% 45% 9% 
*percentages are weighted to reflect sampling and response rates 
 
 
Page 76 of 76Cancer
This article is protected by copyright. All rights reserved.
